Status and progress in the treatment for locally resectable progressive gastric cancer and metastatic gastric cancer
1. Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha 410008; 2. Department of Gastrointestinal and Pancreatic Surgery, Nanjing Jiangning Hospital, Nanjing 211100, China
Abstract：For resectable gastric cancer, although radical surgery is still the main treatment, methods
of operation and the curative effect of operation are still in the stage of exploration for
metastatic gastric cancer. Radiotherapy, chemotherapy and molecular targeted therapy also
play an important role in prolonging the survival period of patients with gastric cancer.
Postoperative radiotherapy and chemotherapy can prolong the survival time, but for
patients with locally advanced gastric cancer, the preoperative radiotherapy and
chemotherapy can also further improve the survival period of patients compared with direct
operation. In addition, with the development and using of molecular targeted drugs, such as
antiangiogenic agents, immunosuppressive drugs and so on, the survival period of patients with gastric cancer has been further extended.
廖孝枫，刘合利，刘鹏. 可切除的局部进展期胃癌及转移性胃癌治疗现状及进展[J]. 中南大学学报(医学版), 2020, 45(4): 426-434.
LIAO Xiaofeng, LIU Heli, LIU Peng. Status and progress in the treatment for locally resectable progressive gastric cancer and metastatic gastric cancer. Journal of Central South University(Medical Scienc, 2020, 45(4): 426-434.
